Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Tirzepatide decreased numerous measures of appetite or the drive to eat ... two important hormone pathways that help control hunger. As of today, there are no medications on the market that purely ...

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body weight, food intake and many measures of appetite more than placebo and ...

Key TakeawaysThe weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer. Tumor ...

Pennington Biomedical researchers and their collaborators observed decreased activity in the brain regions responsible for ...

Roughly one in three preteens and teens ages 12 to 17 in the United States had prediabetes in 2023, according to new data ...

Preclinical study shows oral PL7737 agonist outperforms tirzepatide alone in rodent models, supporting Palatin’s plans for ...

(1276.HK; 600276.SH) delivered a piece of good news for investors with positive trial data for a dual-acting obesity drug ...

A new study reveals that weight lost with GLP-1 drugs, such as semaglutide, is regained within a year after stopping treatment.

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...